Classification of Anticancer Drugs
| dc.contributor.author | Haneen, Alfazzani | |
| dc.contributor.author | Heba, Alnager | |
| dc.contributor.author | Khalid, Altagori | |
| dc.date.accessioned | 2018-03-13T10:10:19Z | |
| dc.date.available | 2018-03-13T10:10:19Z | |
| dc.date.issued | 2018-03-12 | |
| dc.description | Cancer treatment varies from person to person depending on the type, location and size of the cancerous tumor and the Patient's health status. Most treatments are designed to kill or remove infected cells directly or to stimulate the body's own defense against them | en_US |
| dc.description.abstract | Classification of Anticancer Drugs | en_US |
| dc.identifier.uri | http://repository.limu.edu.ly/handle/123456789/223 | |
| dc.publisher | Libyan International Medical University Faculty of Pharmacy | en_US |
| dc.rights | Attribution 3.0 United States | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
| dc.subject | Faculty of Pharmacy | en_US |
| dc.subject | Poster Presentations | en_US |
| dc.subject | Pharm-D | en_US |
| dc.title | Classification of Anticancer Drugs | en_US |
| dc.type | Presentation | en_US |